Novartis Beats Zometa Injury Suit At 2nd Circ.
The Second Circuit on Wednesday affirmed a jury win for Novartis Pharmaceuticals Corp. in a case where a widow accused its drug Zometa of causing her husband's jaw disease, ruling that...To view the full article, register now.
Already a subscriber? Click here to view full article